Skip to main content
Caplight Logo









Diagnocat

Diagnocat

Private
Miami, FloridaHealthcare & Life Scienceshttps://diagnocat.com/en

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Diagnocat operates in Healthcare & Life Sciences and is based in Miami, Florida. It was founded in 2017.

Diagnocat is a healthtech company that provides an AI-powered software platform for the analysis of 2D and 3D dental images to assist with diagnostics and treatment planning.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Vertical SaaS, Healthcare Analytics, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Diagnocat Comparables

Compare Diagnocat with similar companies based on industry and business-model similarity.

Diagnocat comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Velmeni AI
88%
Denti.AI
88%
Pearl
88%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Diagnocat Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Diagnocat. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Matvey Ezhov

Co-founder & CTO

Founding Team

Alex Sanders

CEO, Founder

Founding Team

Ruud Janssen EMBA

Global CFO

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 214% MoM, reaching 42K.

  • Jan 19, 2026

    Monthly visitors increased 56% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Diagnocat Filings

Explore SEC and related filing metadata, where available.

Diagnocat filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Diagnocat's valuation, stock price, and market status.

Is Diagnocat a public or private company?

Diagnocat is a private company.

What is the current stock price of Diagnocat?

Diagnocat is a private company, so its shares have no public market price. Caplight tracks Diagnocat's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Diagnocat worth (valuation)?

Valuation information for Diagnocat is not publicly available.

Can I buy Diagnocat stock?

Diagnocat shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Diagnocat's last funding round?

Funding round information for Diagnocat is not publicly available.

Who are the main investors in Diagnocat?

Investor information for Diagnocat is not publicly disclosed.

Will Diagnocat IPO soon?

No public IPO plans have been announced for Diagnocat.

How can I track Diagnocat secondary market activity?

Caplight tracks bids, offers, and trades in Diagnocat's shares on secondary markets.

Firmographic Details

HeadquartersMiami, Florida
Employee Range64
Year Founded2017
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?